Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.

Yadav VK, Balaji S, Suresh PS, Liu XS, Lu X, Li Z, Guo XE, Mann JJ, Balapure AK, Gershon MD, Medhamurthy R, Vidal M, Karsenty G, Ducy P.

Nat Med. 2010 Mar;16(3):308-12. doi: 10.1038/nm.2098. Epub 2010 Feb 7.

2.

Regulation of bone mass by serotonin: molecular biology and therapeutic implications.

Karsenty G, Yadav VK.

Annu Rev Med. 2011;62:323-31. doi: 10.1146/annurev-med-090710-133426. Review.

PMID:
21073335
3.

[Control of bone remodeling by nervous system. The role of serotonin in the regulation of bone metabolism].

Inose H.

Clin Calcium. 2010 Dec;20(12):1850-956. doi: CliCa101218501956. Review. Japanese.

PMID:
21123937
4.

The importance of the gastrointestinal tract in the control of bone mass accrual.

Karsenty G, Gershon MD.

Gastroenterology. 2011 Aug;141(2):439-42. doi: 10.1053/j.gastro.2011.06.011. Epub 2011 Jun 17. Review.

5.

The two faces of serotonin in bone biology.

Ducy P, Karsenty G.

J Cell Biol. 2010 Oct 4;191(1):7-13. doi: 10.1083/jcb.201006123. Review.

6.

[Serotonin, two faces of a unique molecule in the regulation of bone mass].

Oury F, Karsenty G.

Med Sci (Paris). 2010 Aug-Sep;26(8-9):713-8. doi: 10.1051/medsci/2010268-9713. Review. French.

7.

New anabolic therapies in osteoporosis.

Rubin MR, Bilezikian JP.

Curr Opin Rheumatol. 2002 Jul;14(4):433-40. Review.

PMID:
12118181
8.

Strontium ranelate: a physiological approach for optimizing bone formation and resorption.

Marie PJ.

Bone. 2006 Feb;38(2 Suppl 1):S10-4. Epub 2006 Jan 24. Review.

PMID:
16439191
9.

Combination therapy: the Holy Grail for the treatment of postmenopausal osteoporosis?

Lewiecki EM.

Curr Med Res Opin. 2011 Jul;27(7):1493-7. doi: 10.1185/03007995.2011.591783. Epub 2011 Jun 13. Review.

PMID:
21668289
10.

New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs.

Brandi ML.

Am J Med. 1993 Nov 30;95(5A):69S-74S. Review.

PMID:
8256800
11.

Strontium ranelate in osteoporosis.

Reginster JY.

Curr Pharm Des. 2002;8(21):1907-16. Review.

PMID:
12171530
12.

Lrp5 and bone formation : A serotonin-dependent pathway.

Yadav VK, Ducy P.

Ann N Y Acad Sci. 2010 Mar;1192:103-9. doi: 10.1111/j.1749-6632.2009.05312.x. Review.

PMID:
20392224
13.

Perspectives on osteoporosis therapies.

Cairoli E, Zhukouskaya VV, Eller-Vainicher C, Chiodini I.

J Endocrinol Invest. 2015 Mar;38(3):303-11. doi: 10.1007/s40618-014-0236-9. Epub 2015 Jan 11. Review.

PMID:
25577263
14.

Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.

Marie PJ, Kassem M.

Eur J Endocrinol. 2011 Jul;165(1):1-10. doi: 10.1530/EJE-11-0132. Epub 2011 May 4. Review.

15.

Miscellaneous and experimental agents.

Reginster JY.

Am J Med Sci. 1997 Jan;313(1):33-40. Review.

PMID:
9001164
16.

Anabolic therapy for osteoporosis: parathyroid hormone.

Cosman F.

Curr Osteoporos Rep. 2005 Dec;3(4):143-9. Review.

PMID:
16303114
17.

[Serotonin: a messenger between the brain/small intestine and the skeleton. Animal models strengthen the hypothesis about the role of serotonin in bone formation].

Lerner UH, Ohlsson C, Ahlman H, Mellström D.

Lakartidningen. 2011 Mar 16-22;108(11):600-5. Review. Swedish. No abstract available.

PMID:
21516677
18.

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.

Riggs BL, Parfitt AM.

J Bone Miner Res. 2005 Feb;20(2):177-84. Epub 2004 Nov 16. Review.

19.

[Therapeutic agents for disorders of bone and calcium metabolism: ED-71].

Tsuji N, Takahashi F.

Clin Calcium. 2007 Jan;17(1):72-9. Review. Japanese.

PMID:
17211096
20.

Statins and osteoporosis: new role for old drugs.

Jadhav SB, Jain GK.

J Pharm Pharmacol. 2006 Jan;58(1):3-18. Review.

PMID:
16393459

Supplemental Content

Support Center